Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue

The aim of this study was to investigate the expression of Ki-67, bcl-2 and p53 in parathyroid adenomas and their residual rim of normal parathyroid tissue. Specimens from 26 parathyroid adenomas were studied by immunohistochemical analysis for Ki-67, bcl-2 and p53 expression. Positive findings were noted for p53 in 4 (15%) adenomas and none of the residual rims of normal parathyroid tissue (p = 0.055); for Ki-67 in 15 (56%) adenomas and none of the residual rims of normal parathyroid tissue (p = 0.00002); and for bcl-2 in 19 (73%) adenomas and 8 (31%) residual rims of normal parathyroid tissue (p < 0.01). The high rate of Ki-67 expression may indicate susceptibility of parathyroid adenomas to clonal proliferation. The weak immunoreactive expression of p53, combined with a relatively strong expression of bcl-2, may contribute to the characteristic slow progression of these tumors.

[1]  B. Szende,et al.  Apoptosis and p53, Bcl-2 and bax gene expression in parathyroid glands of patients with hyperparathyroidism , 2008, Pathology & Oncology Research.

[2]  M. Kayath,et al.  A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas. , 1998, European journal of endocrinology.

[3]  A. Arnold,et al.  Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. , 1988, The New England journal of medicine.

[4]  M. Levine,et al.  Absence of p53 point mutations in parathyroid adenoma and carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  K. H. Gülkesen,et al.  EGFR and p53 expression and proliferative activity in parathyroid adenomas; an immunohistochemical study , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  S. Korsmeyer,et al.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Rademaker,et al.  Histopathologic findings of duodenal biopsy specimens in HIV-infected patients with and without diarrhea and malabsorption. , 1992, American journal of clinical pathology.

[8]  R. Warnke,et al.  Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. , 1993, The American journal of pathology.

[9]  C. Marcocci,et al.  Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues , 1998, Journal of endocrinological investigation.

[10]  M. Loda,et al.  Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. , 1994, Human pathology.

[11]  A. Arnold,et al.  Clonal loss of one chromosome 11 in a parathyroid adenoma. , 1989, The Journal of clinical endocrinology and metabolism.

[12]  E. Lalani,et al.  bcl-2: role in epithelial differentiation and oncogenesis. , 1996, Human pathology.

[13]  P. Aló,et al.  P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids. , 2002, Annals of diagnostic pathology.

[14]  S. Korsmeyer,et al.  Bcl-2 protein expression during murine development. , 1994, The American journal of pathology.

[15]  Gwyn T. Williams.  Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[16]  N. Kimura,et al.  The parathyroid adenoma. A histopathologic definition with a study of 172 cases of primary hyperparathyroidism. , 1984, The American journal of pathology.

[17]  M. Kayath,et al.  Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis , 1998, Histopathology.

[18]  P. Wollan,et al.  Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas , 1995, Endocrine pathology.

[19]  M. Papotti,et al.  Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. , 1995, Human pathology.

[20]  L. Grimelius,et al.  Detection of apoptotic cells and expression of Ki‐67 antigen, Bcl‐2, p53 oncoproteins in human parathyroid adenoma , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[22]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[23]  C. Cordon-Cardo,et al.  Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. , 2003, Human pathology.

[24]  D. Louis,et al.  p53 abnormalities in human parathyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[25]  M. Merino,et al.  The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  D. Carney,et al.  Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. , 1992, American journal of clinical pathology.

[27]  R. Metcalf,et al.  Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. , 1991, Cancer research.

[28]  K. Kakudo,et al.  Overexpression and genetic abnormality of p53 in parathyroid adenomas , 1999, Pathology international.

[29]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[30]  C. Sarkar,et al.  MIB-1 proliferative index in parathyroid adenoma & hyperplasia. , 1997, The Indian journal of medical research.

[31]  D. Carson,et al.  Apoptosis and disease , 1993, The Lancet.